(Q40618871)

22 September 2017

title

Up-front chemotherapy with fotemustine (F) / cisplatin (CDDP) / etoposide (VP16) regimen in the treatment of 33 non-removable glioblastomas (English)

1 reference

22 September 2017

1 reference

1 reference

Frenay M

1

1 reference

22 September 2017

Lebrun C

2

1 reference

22 September 2017

Lonjon M

3

1 reference

22 September 2017

Bondiau PY

4

1 reference

22 September 2017

Chatel M

5

1 reference

22 September 2017

language of work or name

1 reference

1 May 2000

1 reference

European Journal of Cancer

22 September 2017

published in

1 reference

22 September 2017

volume

36

1 reference

22 September 2017

issue

8

1 reference

22 September 2017

page(s)

1026-1031

1 reference

Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials.

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900048-4

7 January 2021

Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900048-4

7 January 2021

Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900048-4

7 January 2021

Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900048-4

7 January 2021

Phase II study of continuous infusion carmustine and cisplatin followed by cranial irradiation in adults with newly diagnosed high-grade astrocytoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900048-4

7 January 2021

Successful chemotherapy for recurrent malignant oligodendroglioma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900048-4

7 January 2021

Etoposide (VP-16-213) in malignant brain tumors: a phase II study.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900048-4

7 January 2021

Phase II study of fotemustine in recurrent supratentorial malignant gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900048-4

7 January 2021

Phase II evaluation of high-dose intravenous cisplatin for treatment of adult malignant gliomas recurrent after chloroethylnitrosourea failure

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900048-4

7 January 2021

Response criteria for phase II studies of supratentorial malignant glioma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900048-4

7 January 2021

Quantitative aspects of contrast enhancement in cranial computed tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900048-4

7 January 2021

Treatment of newly diagnosed glioblastoma multiforme with carmustine, cisplatin and etoposide followed by radiotherapy. A phase II study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900048-4

7 January 2021

Adjuvant chemotherapy with carmustine and cisplatin for patients with malignant gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900048-4

7 January 2021

Preirradiation paclitaxel in glioblastoma multiforme: efficacy, pharmacology, and drug interactions. New Approaches to Brain Tumor Therapy Central Nervous System Consortium

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900048-4

7 January 2021

DNA mismatch repair and O6-alkylguanine-DNA alkyltransferase analysis and response to Temodal in newly diagnosed malignant glioma.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900048-4

7 January 2021

Carboplatin chemotherapy before irradiation in newly diagnosed glioblastoma multiforme.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900048-4

7 January 2021

Treatment of recurrent gliomas and metastatic brain tumors with a polydrug protocol designed to combat nitrosourea resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900048-4

7 January 2021

Survival and functional status after resection of recurrent glioblastoma multiforme.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900048-4

7 January 2021

Long-term survival in patients with supratentorial glioblastoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900048-4

7 January 2021

10.1016/S0959-8049(00)00048-4

Identifiers

DOI

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/7ibbwovnbbgfxbf6h5odvt7me4

30 July 2022

mapped directly with Wikidata item

Fatcat ID

release_7ibbwovnbbgfxbf6h5odvt7me4

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/7ibbwovnbbgfxbf6h5odvt7me4

30 July 2022

mapped directly with Wikidata item

https://api.fatcat.wiki/v0/release/7ibbwovnbbgfxbf6h5odvt7me4

1 reference

30 July 2022